Profile for gritetliosidedo
|
SignatureMontelukast was first approved for clinical use by the US FDA in 1998 as Merck's brand name Singulair.The medication is a member of the leukotriene receptor antagonistThere is additional data available for commercial users including Adverse Effects, Contraindications, and Blackbox Warnings....
|
